Autistics Clinically Proven Mercury Poisoned

[Guest guest]

I am forwarding this post from Bernie Windham re: mercury's role in autism.

Bernie has a huge website addressing mercury in medicine and dentistry. Will

send links to his site as soon as I can. Thunderstorms in the area have kept me

off the computer. Nobody else I know has done a more thorough job of gathering

mercury research together in one place than Bernie Windham. Mercury

intoxication is very hard to correct, even with chelation therapy. Chelation

can erradicate the body burden of mercury but it cannot repair all the damage

done to the brain and nervous system by the mercury's presence in the first

place.

Kindest regards to all..................Betsy

 

 

 

Bernard Windham <berniew1 wrote: Autistics Clinically

Proven Mercury Poisoned

 

 

Press Release Contact:

 

For Immediate Release CoMeD Director [Rev. Sykes (Richmond, VA) 804-364-8426]

 

April 8, 2007 CoMeD Sci. Advisor [Dr. King (Lake Hiawatha, NJ) 973-997-1321]

 

 

 

WASHINGTON, DC - Recent peer-reviewed scientific/medical studies by Nataf et al.

(2006) and by Geier and Geier (2006) leave little doubt that many children with

autism spectrum disorders (ASDs) are indeed mercury poisoned. These studies

utilized urinary porphyrin profile analysis (UPPA) to assess body-burden and

physiological effects of mercury in autistics. Today, any parent, physician, or

healthcare provider can easily confirm whether a non-chelated autistic is

mercury poisoned by having UPPA testing run at Laboratory Corporation of America

(LabCorp) (CLIA-certified, Test#120980) or Laboratoire Philippe Auguste

(ISO-certified, Urine Porphyrin Profile).

 

UPPA is a highly accurate, inexpensive, non-invasive, and routinely available

method for estimating body-burden and toxicity of mercury. Numerous

peer-reviewed scientific/medical papers published over the past 40 years, many

of them supported by the US NIH, have proven the validity of using UPPA to

identify mercury poisoning.

 

UPPA profiling, unlike attempts to directly measure mercury in the blood, urine

or feces, or in tissues (e.g., hair and nail), is a proven method for assessing

mercury toxicity.

 

Using UPPA, Nataf et al. (2006) studied the urinary porphyrin patterns in French

children using the results reported by Laboratoire Philippe Auguste. Similarly,

Geier and Geier (2006) studied the urinary porphyrin patterns in US children

using the results reported by LabCorp.

 

Both published studies:

 

· Clearly demonstrated that non-chelated autistics had porphyrin patterns

indicative of clinical mercury toxicity, while normal children and their normal

sibling controls did not.

 

· Found that the more severely affected the ASD children were the higher their

evidence of mercury toxicity.

 

· Established that treating autistics with chelating agents resulted in lower

mercury-specific urinary porphyrins, which corresponded to apparent reductions

in the mercury body-burden of these children.

 

Many other physicians who take care of ASD patients have ordered UPPA testing

and confirmed the observations made by Nataf et al. (2006) and Geier and Geier

(2006).

 

Thus, urinary porphyrin profile testing is being successfully used to:

 

· Demonstrate the role of mercury in populations of autistics,

 

· Identify those children and adults who are mercury poisoned, and

 

· Track mercury excretion from affected children undergoing treatment.

 

For the past several years there has been a raging controversy as to whether or

not mercury in medicines, especially in vaccines, has caused the dramatic rise

in the rate of children diagnosed with an ASD. Many experts have insisted ASDs

are caused by some yet-to-be-identified genetic cause. A paper recently

published in Nature Genetics described the results of multi-million-dollar

genetics study (which studied a thousand-plus families with at least two

autistics using in-depth genetic screening). Tellingly, the authors reported,

" None of our linkage results can be interpreted as 'statistically significant'. "

(The Autism Genome Project Consortium, 2007). This makes it unlikely that purely

genetic aberrations ! are t he root cause of most ASD cases.

 

With the current porphyrin study results, public health officials should now

publicly admit what they have been saying in their private transcripts and memos

all along: Mercury from Thimerosal-containing vaccines and other medicines has

been a major cause of ASD cases, which, according to recent CDC (2007)

estimates, may occur one in every 150 children.

 

CoMeD's web site, http://www.Mercury-freeDrugs.org contains:

 

· Further information on how to order these tests,

 

· Full copies of the Nataf et al. (2006) and Geier and Geier (2006) papers, and

 

· Some of the many published papers validating the UPPA test.